Pacira BioSciences, Inc. SEC filings PCRX
Pacira BioSciences, Inc. has 1,002 filings in SEC EDGAR's recent list, going back to Mar 31, 2014. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 4, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 8, 2026 (material agreement, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Apr 28, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Apr 29, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Feb 27, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Apr 22, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Feb 29, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | Apr 21, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Feb 28, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Feb 28, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 1, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Feb 21, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Feb 28, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Feb 28, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Mar 1, 2017 | Dec 31, 2016 |
| 10-K | Annual report | Feb 25, 2016 | Dec 31, 2015 |
| ARS | Annual report to shareholders | May 5, 2015 | Dec 31, 2014 |
| 10-K | Annual report | Feb 24, 2015 | Dec 31, 2014 |
Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PCRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Brisbane, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1396814
- Former names
- Pacira Pharmaceuticals, Inc. (until Apr 9, 2019); PACIRA INC (until Nov 5, 2008); Blue Acquisition Corp (until Apr 16, 2007)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.